JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A2576 E-64
2 Citation

Target: Cathepsins|Calpains|Papains

Summary: Cysteine protease inhibitor,irriversible

≥49.1 mg/mL
A2602 Calpain Inhibitor I, ALLN
2 Citation

Target: Cathepsins|Calpains

Summary: Calpain I/II/ B/L inhibitor
A1926 CA 074
2 Citation

Target: Cathepsins

Summary: Cathepsin B inhibitor

≥19.17 mg/mL
A3284 Cathepsin S inhibitor
1 Citation

Target: Cathepsins

Summary: Blocks MHCII antigen presentation

≥24.25 mg/mL
A2570 Leupeptin, Microbial

Target: Cathepsins|Calpains|Trypsins

Summary: Inhibitor of serine and cysteine proteases

≥24.7 mg/mL
A4412 MDL 28170

Target: Cathepsins|Calpains

Summary: Calpain and cathepsin B inhibitor, selective

insoluble in H2O; ≥16.75 mg/mL
A4424 SID 26681509

Target: Cathepsins

Summary: Human cathepsin L inhibitor,potent and reversible

<26.98 mg/mL
A8239 CA-074 Me
7 Citation

Target: Cathepsins

Summary: Cathepsin B inhibitor

insoluble in H2O; ≥19.88 mg/mL
A2487 Odanacatib (MK-0822)

Target: Cathepsins

Summary: Cathepsin K,potent and selective

insoluble in EtOH; insoluble in H2O; ≥17.7 mg/mL